Relative contributions of the Candida albicans ABC transporters Cdrlp and Cdr2p to clinical azole resistance

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 4, 2009, Pages 1344-1352

  Tsao, Sarah ^a,b   Rahkhoodaee, Fariba ^a   Raymond, Martine ^a,b,c  

^a INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; CDR1P PROTEIN; CDR2P PROTEIN; FLUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE; PYRROLE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR TAC1P; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; CANDIDA ALBICANS; CDR1 GENE; CDR2 GENE; CONTROLLED STUDY; FUNGAL GENE; FUNGAL STRAIN; GENE DELETION; GENE MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTIFUNGAL AGENTS; ATP-BINDING CASSETTE TRANSPORTERS; AZOLES; CANDIDA ALBICANS; DRUG RESISTANCE, FUNGAL; FLUCONAZOLE; FUNGAL PROTEINS; ITRACONAZOLE; KETOCONAZOLE; MEMBRANE TRANSPORT PROTEINS; MICROBIAL SENSITIVITY TESTS; RHODAMINES;

EID: 65749096905     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00926-08     Document Type: Article

References (46)

1. Akins, R. A. 2005. An update on antifungal targets and mechanisms of resistance in Candida albicans. Med. Mýcol. 43:285-318. (Pubitemid 41030457)
2. Balzi, E., M. Wang, S. Leterme, D. L. Van, and A. Goffeau. 1994. PDR5, a novel yeast multidrug resistance conferring transporter controlled by the transcription regulator PDRl. J. Biol. Chem. 269:2206-2214. (Pubitemid 24035434)
3. Banerjee, D., N. Martin, S. Nandi, S. Shukla, A. Dominguez, G. Mukho-padhyay, and R. Prasad. 2007. A genome-wide steroid response study of the major human fungal pathogen Candida albicans. Mycopathologia 164:1-17. (Pubitemid 46988162)
4. Coste, A., A. Selmecki, A. Forche, D. Diogo, M. E. Bougnoux, C. d'Enfert, J. Berman, and D. Sanglard. 2007. Genotypic evolution of azole resistance mechanisms in sequential Candida albicans isolates. Eukaryot. Cell 6:1889-1904. (Pubitemid 47585577)
5. Coste, A., V. Turner, F. Ischer, J. Morschhäuser, A. Forche, A. Selmecki, J. Berman, J. Bille, and D. Sanglard. 2006. A mutation in Taclp, a transcription factor regulating CDPJ and CDR2, is coupled with loss of heterozygosity at chromosome 5 to mediate antifungal resistance in Candida albicans. Genetics 172:2139-2156.
6. Coste, A. T., M. Karababa, F. Ischer, J. Bille, and D. Sanglard. 2004. TACl. transcriptional activator of CDR genes, is a new transcription factor involved in the regulation of Candida albicans ABC transporters CDRl and CDR2. Eukaryot. Cell 3:1639-1652. (Pubitemid 40025121)
7. Daleké, D. L. 2008. Regulation of phospholipid asymmetry in the erythrocyte membrane. Curr. Opin. Hematol. 15:191-195. (Pubitemid 37303867)
8. Decottignies, A., A. M. Grant, J. W. Nichols, H. de Wet, D. B. Mcintosh, and A. Goffeau. 1998. ATPase and multidrug transport activities of the overex-pressed yeast ABC protein Yorlp. J. Biol. Chem. 273:12612-12622. (Pubitemid 28240639)
9. de Micheli, M., J. Bille, C. Schueller, and D. Sanglard. 2002. A common drag-responsive element mediates the upregulation of the Candida albicans ABC transporters CDRl and CDR2, two genes involved in antifungal drug resistance. MoI. Microbiol. 43:1197-1214. (Pubitemid 34304537)
10. Dunkel, N., T. T. Liu, K. S. Barker, R. Homayouni, J. Morschhäuser, and P. D. Rogers. 2008. A gain-of-function mutation in the transcription factor Upc2p causes upregulation of ergosterol biosynthesis genes and increased fluconazole resistance in a clinical Candida albicans isolate. Eukaryot. Cell 7:1180-1190.
11. Ernst, R., P. Kueppers, C. M. Klein, T. Schwarzmueller, K. Kuchler, and L. Schmitt. 2008. A mutation of the H-loop selectively affects rhodamine transport by the yeast multidrug ABC transporter Pdr5. Proc. Natl. Acad. Sci. USA 105:5069-5074.
12. Gauthier, C, S. Weber, A. M. Alarco, O. Alqawi, R. Daoud, E. Georges, and M. Raymond. 2003. Functional similarities and differences between Candida albicans Cdrlp and Cdr2p transporters. Antimicrob. Agents Chemother. 47:1543-1554. (Pubitemid 36548535)
13. Gillum, A. M., E. Y. Tsay, and D. R. Kirsch. 1984. Isolation of the Candida albicans gene for orotidine-5'-phosphate decarboxylase by complementation of S. cerevisiae ura3 and E. coli pyrF mutations. Mol. Gen. Genet. 198:179-182. (Pubitemid 15180998)
14. Jha, S., N. Dabas, N. Karnani, P. Saini, and R. Prasad. 2004. ABC multidrug transporter Cdrlp of Candida albicans has divergent nucleotide-binding do-mains which display functional asymmetry. FEMS Yeast Res. 5:63-72. (Pubitemid 39307049)
15. Lamping, E., B. C. Monk, K. Niimi, A. R. Holmes, S. Tsao, K. Tanabe, M. Niimi, Y. Uehara, and R. D. Cannon. 2007. Characterization of three classes of membrane proteins involved in fungal azole resistance by functional hyperexpression in Saccharomyc.es cerevisiae. Eukaiyot. Cell 6:1150-1165. (Pubitemid 47077167)
16. Liu, T. T., S. Znaidi, K. S. Barker, L. Xu, R. Homayouni, S. Saidane, J. Morschhäuser, A. Nantel, M. Raymond, and P. D. Rogers. 2007. Genome-wide expression and location analyses of the Candida albicans Taclp regu-lem. Eukaryot. Cell 6:2122-2138. (Pubitemid 350221281)
17. Loftier, J., H. Einsele, H. Hebart, U. Schumacher, C. Hrastnik, and G. Daum. 2000. Phospholipid and sterol analysis of plasma membranes of azole-resistant Candida albicans strains. FEMS Microbiol. Lett. 185:59-63. (Pubitemid 30145607)
18. Lomovskaya, O. 2002. Interactions among multiple efflux pumps: additive and synergistic effects on antimicrobial resistance, abstr. 1188. In Abstr. 42nd Intersci. Conf. Antimicrob. Agents Chemother. American Society for Microbiology, Washington, DC.
19. Maebashi, K., M. Niimi, M. Kudoh, F. J. Fischer, K. Makimura, K. Niimi, R. J. Piper, K. Uchida, M. Arisawa, R. D. Cannon, and H. Yamaguchi. 2001. Mechanisms of fluconazole resistance in Candida albicans isolates from Japanese AIDS patients. J. Antimicrob. Chemother. 47:527-536. (Pubitemid 32447638)
20. Maesaki, S., P. Marichal, H. Vanden Bossche, D. Sanglard, and S. Kohno. 1999. Rhodamine 6G efflux for the detection of CDÄ/-overexpressing azole-resistant Candida albicans strains. J. Antimicrob. Chemother. 44:27-31. (Pubitemid 29353679)
21. Mathews, H. L., and L. Witek-Jaunsek. 2002. Host defense against oral, esophageal, and gastrointestinal candidiasis, p. 179-192. In R. A. Calderone (ed.), Candida and candidiasis. ASM. Press, Washington, DC.
22. Morschhaäuser, J., K. S. Barker, T. T. Liu, J. Blaß-Warmuth, R. Homayouni, and P. D. Rogers. 2007. The transcription factor Mrrlp controls expression of the MDRl efflux pump and mediates multidrug resistance in Candida albicans. PLoS Pathog. 3:1603-1616. (Pubitemid 350291598)
23. Niimi, M., K. Niimi, Y. Takáno, A. R. Holmes, F. J. Fischer, Y. Uehara, and R. D. Cannon. 2004. Regulated overexpression of CDRl in Candida albicans confers multidrug resistance. J. Antimicrob. Chemother. 54:999-1006. (Pubitemid 40136731)
24. Odds, F. C, A. J. Brown, and N. A. Gow. 2003. Antifungal agents: mechanisms of action./ Trends Microbiol. 11:272-279. (Pubitemid 36725017)
25. Prasad, R., P. De Wergifosse, A. GofFeau, and E. Balzi. 1995. Molecular cloning and characterization of a novel gene of Candida albicans, CDRl, conferring multiple resistance to drugs and antifungals. Curr. Genet. 27:320-329.
26. Rai, V., S. Shukla, S. Jha, S. S. Komath, and R. Prasad. 2005. Functional characterization of N-terminal nucleotide binding domain (NBD-I) of a major ABC drug transporter Cdrlp of Candida albicans: uncommon but conserved Trp326 of Walker B is important for ATP binding. Biochemistiy 44:6650-6661. (Pubitemid 40593815)
27. Raychaudhuri, S., and W. A. Prinz. 2006. Uptake and trafficking of exoge-nous sterols in Saccharomyces cerevisiae. Biochem. Soc. Trans. 34:359-362. (Pubitemid 43953986)
28. Reuss, O., A. Vik, R. Kolter, and J. Morschhäuser. 2004. The SATl flipper, an optimized tool for gene disruption in Candida albicans. Gene 341:119-127. (Pubitemid 39335889)
29. Romsicki, Y., and F. J. Sharom. 1999. The membrane lipid environment modulates drug interactions with the P-glycoprotein multidrug transporter. Biochemistry 38:6887-6896. (Pubitemid 129514990)
30. Saidane, S., S. Weber, X. De Deken, G. St-Germain, and M. Raymond. 2006. řDR.Í<>-mediated azole resistance in Candida albicans. MbI. Microbiol. 60: 1546-1562.
31. Saini, P., N. A. Gaur, and R. Prasad. 2006. Chimeras of the ABC drug transporter Cdrlp reveal functional indispensability of transmembrane do-mains and nucleotide-binding domains, but transmembrane segment 12 is replaceable with the corresponding homologous region of the non-drug transporter Cdr3p. Microbiology 152:1559-1573. (Pubitemid 43757711)
32. Sanglard, D., F. Ischer, M. Monod, and J. Bille. 1997. Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characteriza-tion of CDR2, a new multidrug ABC transporter gene. Microbiology 143: 405-416. (Pubitemid 27092176)
33. Sanglard, D., F. Ischer, M. Monod, and J. Bille. 1996. Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors. Antimicrob. Agents Chemother. 40:2300-2305. (Pubitemid 26328036)
34. Sanglard, D., K. Kuchler, F. Ischer, J. L. Pagani, M. Monod, and J. Bille. 1995. Mechanisms of resistance to azole antifungal agents in Candida albi-cans isolates from AIDS patients involve specific multidrug transporters. Antimicrob. Agents Chemother. 39:2378-2386.
35. Schuetzer-Muehlbauer, M., B. Willinger, R. Egner, G. Ecker, and K. Kuchler. 2003. Reversal of antifungal resistance mediated by ABC efflux pumps from Candida albicans functionally expressed in yeast. Int. J. Anti-microb. Agents 22:291-300. (Pubitemid 37103216)
36. Shukla, S., V. Rai, P. Saini, D. Banerjee, A. K. Menon, and R. Prasad. 2007. Candida drug resistance protein 1, a major multidrug ATP binding cassette transporter of Candida albicans, translocates fluorescent phospholipids in a reconstituted system. Biochemistry 46:12081-12090. (Pubitemid 350022364)
37. Shukla, S., P. Saini, Smriti, S. Jha, S. V. Ambudkar, and R. Prasad. 2003. Functional characterization of Candida albicans ABC transporter Cdrlp. Eukaryot. Cell 2:1361-1375. (Pubitemid 38047243)
38. Sims, C. R., L. Ostrosky-Zeichner, and J. H. Rex. 2005. Invasive candidiasis in immunocompromised hospitalized patients. Arch. Med. Res. 36:660-671. (Pubitemid 41436235)
39. Smriti, S. Krishnamurthy, B. L. Dixit, C. M. Gupta, S. Milewski, and R. Prasad. 2002. ABC transporters Cdrlp, Cdr2p and Cdr3p of a human patho-gen Candida albicans are general phospholipid translocators. Yeast 19:303-318. (Pubitemid 34211060)
40. Smriti, S. S. Krishnamurthy, and R. Prasad. 1999. Membrane fluidity affects functions of Cdrlp, a multidrug ABC transporter of Candida albicans. FEMS Microbiol. Lett. 173:475-481.
41. Taglicht, D., and S. Michaelis. 1998. Saccharomyces cerevisiae ABC proteins and their relevance to human health and disease. Methods Enzymol. 292: 130-162. (Pubitemid 29343884)
42. van den Hazel, H. B., H. Pichler, M. A. do Valle Matta, E. Leitner, A. GofFeau, and G. Daum. 1999. 274:1934-1941. (Pubitemid 29061340)
43. Verrier, P. J., D. Bird, B. Burla, E. Dassa, C. Forestier, M. Geisler, M. Klein, U. Kolukisaoglu, Y. Lee, E. Martinoia, A. Murphy, P. A. Rea, L. Samuels, B. Schulz, E. J. Spalding, K. Yazaki, and F. L. Theodoulou. 2008. Plant ABC proteins-a unified nomenclature and updated inventory. Trends Plant Sci. 13:151-159.
44. White, T. C, K. A. Marr, and R. A. Bowden. 1998. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin. Micro-biol. Rev. 11:382-402. (Pubitemid 28197359)
45. Wirsching, S., S. Michel, and J. Morschhäuser. 2000. Targeted gene disrup-tion in Candida albicans wild-type strains: the role of the MDRl gene in fluconazole resistance of clinical Candida albicans isolates. Mol. Microbiol. 36:856-865. (Pubitemid 30326531)
46. Znaidi, S., X. De Deken, S. Weber, T. Rigby, A. Nantel, and M. Raymond. 2007. The zinc cluster transcription factor Taclp regulates PDR16 expression in Candida albicans. Mol Microbiol. 66:440-452. (Pubitemid 47482385)